M. M. Tuglu Et Al. , "The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines," MOLECULAR MEDICINE REPORTS , vol.17, no.1, pp.2033-2043, 2018
Tuglu, M. M. Et Al. 2018. The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines. MOLECULAR MEDICINE REPORTS , vol.17, no.1 , 2033-2043.
Tuglu, M. M., Bostanabad, S. Y., Ozyon, G., Dalkilic, B., & GÜRDAL, H., (2018). The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines. MOLECULAR MEDICINE REPORTS , vol.17, no.1, 2033-2043.
Tuglu, Matilda Et Al. "The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines," MOLECULAR MEDICINE REPORTS , vol.17, no.1, 2033-2043, 2018
Tuglu, Matilda M. Et Al. "The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines." MOLECULAR MEDICINE REPORTS , vol.17, no.1, pp.2033-2043, 2018
Tuglu, M. M. Et Al. (2018) . "The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines." MOLECULAR MEDICINE REPORTS , vol.17, no.1, pp.2033-2043.
@article{article, author={Matilda Merve Tuglu Et Al. }, title={The role of dual-specificity phosphatase 1 and protein phosphatase 1 in (2)-adrenergic receptor-mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines}, journal={MOLECULAR MEDICINE REPORTS}, year=2018, pages={2033-2043} }